You have   6 free profiles   left this month    Start Your Free Trial ➤
Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there? View on RelSci Pro ➤

Jeremy Minshull

President & Chief Executive Officer at ATUM
In The News
Career History
Boards & Committees

Jeremy Minshull

President & Chief Executive Officer at ATUM


Notable Companies
Board Seats
Number of Relationships
This person is connected to 118 people.

Relationships See Details

Chief Commercial Officer at ATUM

Adjunct Associate Professor, Department of Plant Breeding & Genetics at Cornell University - College of Agriculture and Life Sciences


Chief Information Officer at ATUM

Chief Scientific Officer at ATUM

Former Chief Executive Officer at Technica Corp.

Interim President & Chief Executive Officer at Envia Systems, Inc.

Former Managing Director Investment at Temasek

President & Chief Executive Officer at Barefoot Networks, Inc.

President, Chief Executive Officer & Director at Calysta, Inc.
See 108 more listings with RelSci Professional.

In The News See More

Business Wire
June 1, 2017
PR Newswire
April 10, 2017
PR Newswire
December 12, 2016
PR Newswire
September 1, 2016
The New York Times
May 14, 2016
See full news coverage and complete stories with RelSci Professional.

Paths to Jeremy Minshull

Jeremy Minshull
Connections via Relationship Science
Jeremy Minshull
Sync your contacts to see how you can connect with Jeremy Minshull.

Educational Background

The University of Cambridge (informally known as Cambridge University or Cambridge) is a public research university located in Cambridge, United Kingdom. It is the second-oldest university in the English-speaking world (after the University of Oxford), and the seventh-oldest in the world.

Career History

President & Chief Executive Officer
2003 - Current
ATUM provides bioengineering solutions. It offers an integrated pipeline of solutions for the research community including platforms for protein and vector engineering, products such as expression vectors, fluorescent and chromogenic proteins, cell strains and reagents, as well as gene design, optimization and cloning. The company was founded in 2003 and is headquartered in Newark, CA.
Vice President-Core Technology
Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA.
At Affymax, our mission is to discover, develop and deliver innovative therapies that improve the lives of patients with kidney disease and other serious and often life-threatening illnesses. Our first marketed product, OMONTYS® (peginesatide) Injection, was approved by the U.S. Food and Drug Administration (FDA) in March 2012. With this approved compound, we plan to establish the company as a supportive partner to physicians and patients

Boards & Committees

Corporate Boards ▾
Calysta, Inc. provides sustainable industrial products for food and energy security. It develops new Biological Gas-to-Liquids and Biological Gas-to-Chemicals technologies using methane, the primary component of natural gas. Its technology allows conversion of a plentiful energy resource into high value chemicals and transportation fuels with cost and performance advantages over current processes. The company was founded in 2011 by Joshua Silverman and is headquartered in Menlo Park, CA.
Calysta Biosystems LLC engages in basic organic chemical manufacturing activities. The company was founded by David McElroy on May 20, 2011 and is headquartered in Menlo Park, CA.

Other Affiliations

Jeremy Minshull is affiliated with ATUM, Maxygen, Inc., Affymax, Inc., Calysta, Inc., Calysta Biosystems LLC.

You've reached your 7 free profiles limit this month.

Upgrade to RelSci Pro today to enjoy unlimited profile views and much more!

Start My Free Trial
Still not convinced? Check out our full listing of features here.